Phoenix Financial (PHOE) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
11 Jun, 2026Executive summary
Achieved comprehensive income of ILS 1.5 billion (NIS 1,509.8 million) in H1 2025, with strong core income and robust performance across insurance and asset management lines.
Return on equity reached 27% in H1 and 35% in Q2, with core ROE at 24% in H1, reflecting high earnings quality.
Assets under management grew to ILS 560 billion (over $160 billion), maintaining a 20% five-year CAGR and reflecting strong organic and inorganic growth.
Announced a quarterly dividend of ILS 400 million and doubled the annual buyback program to ILS 200 million, supporting shareholder returns.
Successful implementation of IFRS 17/9 from January 2025 improved transparency and reduced volatility.
Financial highlights
H1 2025 core income was ILS 1.3 billion (NIS 1,318 million), with Q2 core income of ILS 700 million (NIS 692 million), and comprehensive income of ILS 1.5 billion (NIS 1,509.8 million).
Asset management activities grew over 40% year-over-year, contributing ILS 426 million in H1.
Solvency ratio estimated at 181% as of March 2025, well above regulatory thresholds.
Shareholders’ equity increased to ILS 12.2 billion as of June 30, 2025.
Total assets reached ILS 184.9 billion as of June 30, 2025.
Outlook and guidance
2025 H1 run rate already within or above 2027 target range of ILS 2.4-2.6 billion; targets to be updated in Q4 2025.
Commitment to quarterly dividends and ongoing buybacks, supported by strong internal cash flows.
Strategic focus on capital-efficient, high-ROE activities and maximizing investment performance.
Agencies’ 2027 EBITDA target revised upward to ILS 700–800 million.
MSCI inclusion in Israel index from August, opening further global index opportunities.
Latest events from Phoenix Financial
- Q1 2025 saw strong growth, high ROE, and enhanced capital returns after IFRS 17 adoption.PHOE
Q1 202512 Jun 2026 - H1 2024 delivered ILS 667m income, 12.8% ROE, and strong capital returns amid market volatility.PHOE
Q2 202412 Jun 2026 - Core income, ROE, and AUM surged, with robust solvency and strong segment growth in 2024.PHOE
Q3 202412 Jun 2026 - Comprehensive income up 34–35%, core income up 16%, payout ratio raised to 55%.PHOE
Q4 202511 Jun 2026 - Strong Q3 and 9M results, high ROE, and upgraded 2028 growth targets achieved.PHOE
Q3 202511 Jun 2026 - 2024 comprehensive income hit 2,087 NISm with 18.6% ROE and robust segment growth.PHOE
Q4 202411 Jun 2026 - Q1 2026: 24% income growth, 24% ROE, record AUM, and strong capital returns.PHOE
Q1 202611 Jun 2026